FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913202912> ?p ?o ?g. }

• W2913202912 endingPage "406" @default.
• W2913202912 startingPage "397" @default.
• W2913202912 abstract "Linaclotide is approved for treating irritable bowel syndrome with constipation (IBS-C; 290 µg QD) and chronic idiopathic constipation (CIC; 145 µg or 72 µg QD). These analyses aimed to assess linaclotide safety in a large, pooled Phase 3 population.In six randomized controlled trials (RCTs), patients received linaclotide (72 µg, 145 µg, 290 µg) or placebo daily for 12-26 weeks; in two long-term safety (LTS) studies, patients received open-label linaclotide for ≤78 additional weeks. Laboratory values, vital signs, and treatment-emergent adverse events (TEAEs) were assessed.Overall, 3853 patients received ≥1 dose of linaclotide. The most common TEAE was diarrhea (majority [90.5% in RCTs] mild/moderate). Linaclotide patients experienced 1.1 diarrhea TEAE per patient-year in the RCTs (0.2 in placebo), and 0.3 in the LTS studies. In RCTs, 6.9% linaclotide and 3.0% placebo patients discontinued due to any adverse event (AE); 4.0% linaclotide and 0.3% placebo patients discontinued due to diarrhea. In LTS studies, 9.4% patients discontinued due to any AE, and 3.8% due to diarrhea. Serious AEs (SAEs) were rare and similar across treatment groups; there were no SAEs of diarrhea.These pooled analyses of patients treated for ≤104 weeks confirm linaclotide's overall safety." @default.
• W2913202912 created "2019-02-21" @default.
• W2913202912 creator A5001446657 @default.
• W2913202912 creator A5018204077 @default.
• W2913202912 creator A5027084072 @default.
• W2913202912 creator A5037407546 @default.
• W2913202912 creator A5040662240 @default.
• W2913202912 creator A5048674574 @default.
• W2913202912 creator A5057711127 @default.
• W2913202912 creator A5058573402 @default.
• W2913202912 creator A5061045517 @default.
• W2913202912 creator A5075769916 @default.
• W2913202912 creator A5088620889 @default.
• W2913202912 date "2019-02-18" @default.
• W2913202912 modified "2023-10-17" @default.
• W2913202912 title "Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis" @default.
• W2913202912 cites W1854805108 @default.
• W2913202912 cites W1965194352 @default.
• W2913202912 cites W1973915683 @default.
• W2913202912 cites W1987172422 @default.
• W2913202912 cites W1997800332 @default.
• W2913202912 cites W2009552042 @default.
• W2913202912 cites W2018506474 @default.
• W2913202912 cites W2020188527 @default.
• W2913202912 cites W2045028764 @default.
• W2913202912 cites W2052341274 @default.
• W2913202912 cites W2056304431 @default.
• W2913202912 cites W2079448135 @default.
• W2913202912 cites W2129385409 @default.
• W2913202912 cites W2132145612 @default.
• W2913202912 cites W2171336485 @default.
• W2913202912 cites W2745826951 @default.
• W2913202912 cites W947943188 @default.
• W2913202912 doi "https://doi.org/10.1080/17474124.2019.1575203" @default.
• W2913202912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30791771" @default.
• W2913202912 hasPublicationYear "2019" @default.
• W2913202912 type Work @default.
• W2913202912 sameAs 2913202912 @default.
• W2913202912 citedByCount "13" @default.
• W2913202912 countsByYear W29132029122019 @default.
• W2913202912 countsByYear W29132029122020 @default.
• W2913202912 countsByYear W29132029122021 @default.
• W2913202912 countsByYear W29132029122022 @default.
• W2913202912 countsByYear W29132029122023 @default.
• W2913202912 crossrefType "journal-article" @default.
• W2913202912 hasAuthorship W2913202912A5001446657 @default.
• W2913202912 hasAuthorship W2913202912A5018204077 @default.
• W2913202912 hasAuthorship W2913202912A5027084072 @default.
• W2913202912 hasAuthorship W2913202912A5037407546 @default.
• W2913202912 hasAuthorship W2913202912A5040662240 @default.
• W2913202912 hasAuthorship W2913202912A5048674574 @default.
• W2913202912 hasAuthorship W2913202912A5057711127 @default.
• W2913202912 hasAuthorship W2913202912A5058573402 @default.
• W2913202912 hasAuthorship W2913202912A5061045517 @default.
• W2913202912 hasAuthorship W2913202912A5075769916 @default.
• W2913202912 hasAuthorship W2913202912A5088620889 @default.
• W2913202912 hasBestOaLocation W29132029121 @default.
• W2913202912 hasConcept C126322002 @default.
• W2913202912 hasConcept C142724271 @default.
• W2913202912 hasConcept C197934379 @default.
• W2913202912 hasConcept C204787440 @default.
• W2913202912 hasConcept C27081682 @default.
• W2913202912 hasConcept C2778271842 @default.
• W2913202912 hasConcept C2778375690 @default.
• W2913202912 hasConcept C2779802037 @default.
• W2913202912 hasConcept C2781093762 @default.
• W2913202912 hasConcept C2781112942 @default.
• W2913202912 hasConcept C2908647359 @default.
• W2913202912 hasConcept C3017955636 @default.
• W2913202912 hasConcept C71924100 @default.
• W2913202912 hasConcept C90924648 @default.
• W2913202912 hasConcept C99454951 @default.
• W2913202912 hasConceptScore W2913202912C126322002 @default.
• W2913202912 hasConceptScore W2913202912C142724271 @default.
• W2913202912 hasConceptScore W2913202912C197934379 @default.
• W2913202912 hasConceptScore W2913202912C204787440 @default.
• W2913202912 hasConceptScore W2913202912C27081682 @default.
• W2913202912 hasConceptScore W2913202912C2778271842 @default.
• W2913202912 hasConceptScore W2913202912C2778375690 @default.
• W2913202912 hasConceptScore W2913202912C2779802037 @default.
• W2913202912 hasConceptScore W2913202912C2781093762 @default.
• W2913202912 hasConceptScore W2913202912C2781112942 @default.
• W2913202912 hasConceptScore W2913202912C2908647359 @default.
• W2913202912 hasConceptScore W2913202912C3017955636 @default.
• W2913202912 hasConceptScore W2913202912C71924100 @default.
• W2913202912 hasConceptScore W2913202912C90924648 @default.
• W2913202912 hasConceptScore W2913202912C99454951 @default.
• W2913202912 hasFunder F4320312269 @default.
• W2913202912 hasFunder F4320332585 @default.
• W2913202912 hasIssue "4" @default.
• W2913202912 hasLocation W29132029121 @default.
• W2913202912 hasLocation W29132029122 @default.
• W2913202912 hasOpenAccess W2913202912 @default.
• W2913202912 hasPrimaryLocation W29132029121 @default.
• W2913202912 hasRelatedWork W2034691705 @default.
• W2913202912 hasRelatedWork W2061072501 @default.
• W2913202912 hasRelatedWork W2086376979 @default.
• W2913202912 hasRelatedWork W2103355032 @default.

• next